Method for producing ring-opening metathesis polymer hydride, and resin composition

US9850325B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9850325-B2
Application numberUS-201314385582-A
CountryUS
Kind codeB2
Filing dateMar 14, 2013
Priority dateMar 16, 2012
Publication dateDec 26, 2017
Grant dateDec 26, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method for producing a hydrogenated ring-opening metathesis polymer includes subjecting a cyclic olefin to ring-opening metathesis polymerization in the presence of a polymerization catalyst to produce a ring-opening metathesis polymer, and hydrogenating at least some of carbon-carbon double bonds of the ring-opening metathesis polymer, at least one ruthenium compound selected from a group made of a ruthenium compound represented by a formula (I), (II), (III), and (IV) being used as the polymerization catalyst; and a resin composition having a hydrogenated ring-opening metathesis polymer produced by this method. It is possible to industrially advantageously produce a hydrogenated ring-opening metathesis polymer that exhibits especially excellent light transmittance.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a hydrogenated ring-opening metathesis polymer comprising subjecting a cyclic olefin to ring-opening metathesis polymerization in the presence of a polymerization catalyst to produce a ring-opening metathesis polymer, and hydrogenating at least some of carbon-carbon double bonds of the ring-opening metathesis polymer, the cyclic olefin comprising: (i) a monomer represented by the following formula (2), wherein R 28 is a C 1 -C 20 alkyl group, a C 3 -C 20 cycloalkyl group, a substituted or unsubstituted C 6 -C 20 aryl group, or a group represented by the following formula (3), wherein R 29 is a C 1 -C 3 alkylene group, and R 30 and R 31 are independently a C 1 -C 10 alkyl group or a C 1 -C 10 alkyl halide group, and (ii) a cyclic olefin that includes a protonic polar group, the proportion of the cyclic olefin including a protonic polar group being 10-90 mol % based on the total cyclic olefins, the polymerization catalyst being a ruthenium compound shown by the following formula (I), wherein X 1 and X 2 are independently a halogen atom; L 1 represents a group represented by any of the following formulas (1-1) to (1-3), wherein R 17 and R 18 are independently a phenyl group, 4-methylphenyl group, 2,4-dimethylphenyl group, 2,4,6-trimethylphenyl group, biphenyl group, 1-naphthyl group, 2-naphthyl group, or methylnaphthyl group, R 19 to R 22 are independently a hydrogen atom or a C 1 -C 10 alkyl group, and R 23 to R 25 are independently a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 3 -C 20 cycloalkyl group, a C 6 -C 20 aryl group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 6 -C 20 aryloxy group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, or a C 2 -C 20 heterocyclic group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group; R 0 is a hydrogen atom, a halogen atom, a nitro group, a cyano group, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 1 -C 20 alkylthio group, a tri-C 1 -C 20 alkylsilyl group, a tri-C 1 -C 20 alkylsilyloxy group, a C 6 -C 20 aryl group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 6 -C 20 aryloxy group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 2 -C 20 heterocyclic group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 1 -C 20 alkylsulfonyl group, a C 1 -C 20 alkylsulfinyl group, a formyl group, a C 1 -C 20 alkylcarbonyl group, a C 1 -C 20 alkoxycarbonyl group, a di-C 1 -C 20 alkylcarbamoyl group, a di-C 1 -C 20 alkylureido group, or a di-C 1 -C 20 alkylsulfonylamino group; R 1 is a group represented by (R b1 )(R b2 )NSO 2 —, a formyl group, a C 1 -C 20 alkylcarbonyl group, a C 1 -C 20 alkoxycarbonyl group, a group represented by (R c1 )(R c2 )NCO—, an amide group, a halogen atom, a di-C 1 -C 20 alkylureido group, or a C 1 -C 20 alkylsulfonylamino group, wherein R b1 and R c1 are a hydrogen atom, a C 1 -C 20 alkyl group, or an aryl group, which may be substituted with a halogen atom a C 1 -C 6 alkyl group, C 1 -C 16 alkoxy group, a nitro group, or a cyano group, and R b2 and R c2 are a hydrogen atom, a C 1 -C 20 alkyl group, or an aryl group, which may be substituted with a halogen atom a C 1 -C 6 alkyl group, C 1 -C 16 alkoxy group, a nitro group, or a cyano group, provided that R b1 and R b2 or R c1 and R c2 optionally bond to each other to form a ring; R 2 and R 3 are independently a hydrogen atom, a halogen atom, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 1 -C 20 alkylthio group, a tri-C 1 -C 20 alkylsilyloxy group, a C 6 -C 20 aryloxy group, a C 6 -C 20 aryl group, a C 2 -C 20 heterocyclic group, a C 1 -C 20 alkoxycarbonyl group, a di-C 1 -C 20 alkylcarbamoyl group, a di-C 1 -C 20 alkylureido group, or a C 1 -C 20 alkylsulfonylamino group; R 4 is a hydrogen atom, a C 1 -C 20 alkyl group, a C 1 -C 20 alkoxy group, a C 1 -C 20 alkylthio group, a tri-C 1 -C 20 alkylsilyl group, a tri-C 1 -C 20 alkylsilyloxy group, a C 6 -C 20 aryl group, which may be substituted with a halogen atom, C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 6 -C 20 aryloxy group, which may be substituted with a halogen atom, C 1 -C 6 alkyl group, C 1 -C 6 alkoxy group, a nitro group, or a cyano group, or a C 2 -C 20 heterocyclic group, which may be substituted with a halogen atom, a C 1 -C 6 alkyl group, a C 1 -C 6 alkoxy group, a nitro group, or a cyano group, a C 1 -C 20 alkylsulfonyl group, a C 1 -C 20 alkylsulfinyl group, a C 1 -C 20 alkylcarbonyl group, a C 1 -C 20 alkoxycarbonyl group, a di-C 1 -C 20 alkylcarbamoyl group, a di-C 1 -C 20 alkylureido group, a C 1 -C 20 alkylsulfonylamino group, or a C 6 -C 20 arylcarbonyl group that is optionally substituted with a halogen atom; and Y 1 is an oxygen atom, a sulfur atom, NR b , or PR b , where R b is a hydrogen atom or a C 1 -C 20 alkyl group; wherein the reaction of polymerizing the cyclic olefin by ring-opening metathesis polymerization is conducted in the presence of the polymerization catalyst in an ether-based solvent wherein the ether-based solvent is present in an amount of 0.5-100 parts by weight per one part by weight of the cyclic olefin. 2. The method according to claim 1 , wherein at least 98% of the carbon-carbon double bonds of the ring-opening metathesis polymer are hydrogenated. 3. The method according to claim 1 , wherein the ruthenium compound represented by the formula (I) is a compound represented by a formula (I-2), wherein L 1 , R 0 , R 2 to R 4 , R b1 , and R b2 are the same as defined in claim 1 . 4. The method according to claim 1 , wherein the ruthenium compound represented by the formula (I) is a compound represented by a formula (I-3), wherein R 0 , R 2 to R 4 , R 17 , R 18 , R b1 , and R b2 are the same as defined in claim 1 . 5. The method according to claim 1 , wherein the ruthenium compound represented by the formula (I) is a compound represented by a formula (I-4), wherein R 0 , R 2 to R 4 , R 23 to R 25 , R b1 , and R b2 are the same as defined in claim 1 . 6. A method according to claim 5 , wherein the metathesis polymerization of the cyclic olefin is conducted in the presence of the polymerization catalyst in an ether solvent by a solution polymerization. 7. The method according to claim 2 , wherein the ruthenium compound represented by

Assignees

Inventors

Classifications

  • C08F8/04Primary

    Reduction, e.g. hydrogenation · CPC title

  • TFT applications · CPC title

  • Compositions of macromolecular compounds obtained by reactions forming a carbon-to-carbon link in the main chain (C08L7/00 - C08L57/00, C08L61/00 take precedence); Compositions of derivatives of such polymers · CPC title

  • Use in organic luminescent diodes · CPC title

  • C08G61/08Primary

    of carbocyclic compounds containing one or more carbon-to-carbon double bonds in the ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9850325B2 cover?
A method for producing a hydrogenated ring-opening metathesis polymer includes subjecting a cyclic olefin to ring-opening metathesis polymerization in the presence of a polymerization catalyst to produce a ring-opening metathesis polymer, and hydrogenating at least some of carbon-carbon double bonds of the ring-opening metathesis polymer, at least one ruthenium compound selected from a group ma…
Who is the assignee on this patent?
Zeon Corp
What technology area does this patent fall under?
Primary CPC classification C08F8/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 26 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).